Page 69 - Sohini Das

Data shows India's changing Covid-19 mix as share of omicron samples dips

Govt stopped updating weekly numbers on genetic sequencing in January

Indian home healthcare market to grow 2.5x to $19.9 bn by 2025: Nathealth

The study estimated that the market has a potential to grow an additional $5 bn with the right impetus

Alembic acquires 100% stake in Aleor Dermaceuticals from JV partner

The move is aimed at strengthening its skin-related manufacturing and marketing footprint

Aurobindo's Veritaz acquisition unlikely to add much value: Analysts

Deal is nonetheless a stepping stone in the drug firm's strategic plan to focus on domestic formulations market, where it aims to have Rs 1,000-cr sales in three years

Aurobindo Pharma acquires Veritaz' domestic business for Rs 171 cr

Move marks Aurobindo's increasing focus on Indian market

Alembic Pharma targets 10-12 product filings from Karkhadi facility

Resolution of the observations made by the USFDA (for which Alembic has already responded to the regulator) is critical for Alembic's US business

Gennova's mRNA vaccine in legal storm after HDT Bio Corp sues Emcure

The US firm HDT Bio Corp has alleged that Emcure 'willfully and maliciously' violated the Defend Trade Secrets Act and Washington's laws against trade secret theft

India reports 19% jump in TB cases in 2021: India TB Report

TB notifications started to pick up towards the end of 2020, and a total of 1.8 mn cases could be notified, an increase of 11%

Two years after Covid, experts in India feel it's right time to 'open' up

Gagandeep Kang, microbiologist and professor at CMC, Vellore says this is the right time to relax Covid curbs, but as long as we also plan for worst case scenarios

Reducing dose gap may help liquidate Covishield vaccine stocks faster

Liquidating stocks is critical for SII as it can store around 600-700 million doses at its site.

Serum Institute seeks Covovax EUA for 7- to 11-year age group

Pune-based vaxmaker conducting trials on children aged 2 yrs and above

Centre asks states to end all Covid containment measures from March 31

Masks and social distancing norms will continue: MHA

No more Covid curbs under Disaster Management Act after March 31: MHA

Masks, social distancing norms to continue; States and UTs allowd to issue standard operating procedures (SoPs) for containment measures, vaccination

World's first ayush phase-3 trial for rheumatoid arthritis in India

Study will begin in May, to take two years to complete

FY22 Healthcare hires saw 100-220% growth in specialised roles: TeamLease

Overall employment in sector grew from 6.8 mn in FY21 to 7.5 mn in FY22; about 9.5 mn people likely to be employed by FY26

Wockhardt, Serum Institute of India tie up to make vaccines in UK

SII has supplied the AstraZeneca-Oxford vaccine to the UK already, and having a fill-and-finish facility in the UK would help the firm to have closer access to the UK and EU markets.

Health technology platform Tata 1mg steps up diagnostics play

Since Tata 1mg is focused on online diagnostics and home collection of samples, it has third-party partners for radiology tests

Cloudnine aims to raise Rs 1,200 crore, add 7 hospitals every year

Cloudnine's revenues increased at a CAGR of 15.16 per cent from Rs 418 crore in FY19 to Rs 554 crore in FY21, while its Ebitda increased at a CAGR of 55.8 per cent

TRIPS waiver may have little impact, say Indian vaccine makers

Vaccine industry insiders feel intellectual property rights is not the only or main obstacle to ensure higher access of Covid-19 vaccine

Now, Manipal Hospitals to monitor patients post discharge through Fitbit

Manipal Hospitals said that the service would be voluntary for its patients and offered free of cost for the time-being